Auteurs Jaune E, Cavazza E, Ronco C, Grytsai O, Abbe P, Tekaya N, Zerhouni M, Beranger G, Kaminski L, Bost F, Gesson M, Tulic M, Hofman P, Ballotti R, Passeron T, Botton T, Benhida R, Rocchi S
Cell death & disease Jan 2021
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.Auteurs Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R
Molecular cancer Jan 2021
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease.Auteurs Pandiani C, Strub T, Nottet N, Cheli Y, Gambi G, Bille K, Husser C, Dalmasso M, Béranger G, Lassalle S, Magnone V, Pédeutour F, Irondelle M, Maschi C, Nahon-Estève S, Martel A, Caujolle JP, Hofman P, LeBrigand K, Davidson I, Baillif S, Barbry P, Ballotti R, Bertolotto C
Cell death and differentiation Jan 2021
FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.Auteurs Habel N, El-Hachem N, Soysouvanh F, Hadhiri-Bzioueche H, Giuliano S, Nguyen S, Horák P, Gay AS, Debayle D, Nottet N, Béranger G, Paillerets BB, Bertolotto C, Ballotti R
Cell death and differentiation Jan 2021
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.Auteurs Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R
Molecular cancer Jan 2021
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?Auteurs Ballotti R, Cheli Y, Bertolotto C
Molecular cancer Déc 2020
Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives.Auteurs Martel A, Baillif S, Nahon-Esteve S, Gastaud L, Bertolotto C, Roméo B, Mograbi B, Lassalle S, Hofman P
Cancers Nov 2020
Regulation of Melanogenesis by the Amino Acid Transporter SLC7A5.Auteurs Gaudel C, Soysouvanh F, Leclerc J, Bille K, Husser C, Montcriol F, Bertolotto C, Ballotti R
The Journal of investigative dermatology Nov 2020
The « ART » of Epigenetics in Melanoma: From histone « Alterations, to Resistance and Therapies ».Auteurs Strub T, Ballotti R, Bertolotto C
Theranostics Jan 2020
Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells.Auteurs Bellini L, Strub T, Habel N, Pandiani C, Marchetti S, Martel A, Baillif S, Bailly-Maitre B, Gual P, Ballotti R, Bertolotto C
Cell death discovery Jan 2020